Sungrace Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.26 M
- Company Age 6 Year, 29 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.84 Cr
- Revenue Growth -36.89%
- Profit Growth -4.95%
- Ebitda -31.26%
- Net Worth 28.95%
- Total Assets -5.50%
About Sungrace Pharma
Sungrace Pharma Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2019 (Six years 29 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.26 M.
The company currently has active open charges totaling ₹2.84 Cr.
Sharad Shah, Samir Shah, and Ronak Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110GJ2019PTC106267
- Company No.
106267
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2019
- Date of AGM
17 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Sungrace Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharad Shah  | Director | 25-Jan-2019 | Current |
| Samir Shah | Director | 12-Nov-2021 | Current |
| Ronak Shah | Director | 25-Jan-2019 | Current |
Financial Performance of Sungrace Pharma.
Sungrace Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.89% decrease. The company also saw a slight decrease in profitability, with a 4.95% decrease in profit. The company's net worth Soared by an impressive increase of 28.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sungrace Pharma?
In 2023, Sungrace Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medico Intercontinental LimitedSamir Shah is a mutual person
Kingston Club & Spa Private LimitedSamir Shah is a mutual person
Evagrace Pharma Private LimitedSamir Shah and Ronak Shah are mutual person
Azillian Healthcare Private LimitedSamir Shah is a mutual person
Kings Marvela LlpSamir Shah is a mutual person
- Ritz Formulations Private Limited
Samir Shah is a mutual person
Charges (Loans)
₹28.40 M
₹0
Charges Breakdown by Lending Institutions
- Others : 2.84 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Oct 2020 | Others | ₹1.42 Cr | Open |
| 04 Sep 2020 | Others | ₹1.42 Cr | Open |
How Many Employees Work at Sungrace Pharma?
Sungrace Pharma has a workforce of 9 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sungrace Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sungrace Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.